Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
04/03/2014 | WO2014051215A1 Novel udp-glycosyltransferase derived from ginseng and use thereof |
04/03/2014 | WO2014051214A1 Novel udp-glycosyltransferase derived from ginseng and use thereof |
04/03/2014 | WO2014051111A1 Hepatitis c virus particles formation promoter, and method for producing hepatitis c virus particles |
04/03/2014 | WO2014051109A1 Anti-human bmp9 antibody and treatment agent for ectopic ossification disease containing said antibody as active ingredient |
04/03/2014 | WO2014051076A1 Bna clamp method |
04/03/2014 | WO2014051031A1 Modified dna polymerase |
04/03/2014 | WO2014051022A1 Fgfr3 fusion gene and pharmaceutical drug targeting same |
04/03/2014 | WO2014051009A1 Psoriasis vulgaris model mouse and method for producing same |
04/03/2014 | WO2014050927A1 Va-gene-disrupted adenovirus vector, and precursor vector for preparing same |
04/03/2014 | WO2014050908A1 Polypeptide, scaffold composition, composition for cartilage tissue restoration, composition for cartilage cell culture, and composition for promoting glycosaminoglycan production |
04/03/2014 | WO2014050781A1 Ret inhibitor |
04/03/2014 | WO2014050160A1 Dynamic network biomarker detection device, detection method, and detection program |
04/03/2014 | WO2014050116A1 Eustoma having cytoplasmic male sterility and method for producing said eustoma |
04/03/2014 | WO2014049168A1 Methods for producing recombinant proteins |
04/03/2014 | WO2014049152A1 Methods and pharmaceutical compositions for the treatment of cardiovascular fibrosis |
04/03/2014 | WO2014049125A1 Nucleotide sequence motifs directing nucleic acid location to extracellular vesicles |
04/03/2014 | WO2014049094A1 Recombinant measles virus expressing chikungunya virus polypeptides and their applications |
04/03/2014 | WO2014049002A1 Solanum lycopersicum plants having non-transgenic alterations in the acs4 gene |
04/03/2014 | WO2014048788A1 Methods for producing a population of pancreatic beta-cells |
04/03/2014 | WO2014048500A1 Novel mva virus and uses thereof |
04/03/2014 | WO2014048442A1 Methods and tools for identification of rsk/msk kinase inhibitors |
04/03/2014 | WO2014048441A1 Oligomers with improved off-target profile |
04/03/2014 | WO2014048392A1 Method for producing stevioside compounds by microorganism |
04/03/2014 | WO2014048369A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
04/03/2014 | WO2014048263A1 Method for pressure extraction of nucleic acids and device thereof |
04/03/2014 | WO2014048185A1 Method for enriching transcript from rna sample and use thereof |
04/03/2014 | WO2014047848A1 Modified bcg strains with reduced or eliminated activity of lsr2 and pharmaceutical composition comprising same |
04/03/2014 | WO2014025234A3 Nucleic acid aptamers that specifically bind to cancer stem cells, and use thereof |
04/03/2014 | WO2014025199A3 Staphylococcal enterotoxin-derived superantigen mutant, fusion protein in which target-specific polypeptides are connected to the mutant and use thereof |
04/03/2014 | WO2014025198A3 Lfa3 mutant, fusion protein in which target-specific polypeptides are connected to the mutant or lfa3 cd2 binding region, and use thereof |
04/03/2014 | WO2014024079A3 Fungal resistant plants expressing rlk1 |
04/03/2014 | WO2014022739A3 Modified rnai agents |
04/03/2014 | WO2014022283A3 Glycoprotein hormone long-acting superagonists |
04/03/2014 | WO2014018423A3 Inducible dna binding proteins and genome perturbation tools and applications thereof |
04/03/2014 | WO2014015056A3 Anti-mucus drugs and uses therefor |
04/03/2014 | WO2013192613A3 Pvy resistance |
04/03/2014 | WO2013192576A3 Oligonucleotide-based inhibitors comprising locked nucleic acid motif |
04/03/2014 | WO2013191591A4 Chimeric protein vaccine against pneumonia caused by streptococcus pneumoniae |
04/03/2014 | WO2013167012A3 Synthesis method for l-heterocyclic amino acid and pharmaceutical composition having said acid |
04/03/2014 | WO2013006953A9 Genes and proteins for alkanoyl-coa synthesis |
04/03/2014 | WO2012068344A3 Regulation of cathepsin l by its transcription factor dendrin |
04/03/2014 | WO2012068000A3 Methods of treating cancers with her3 and pik3ca antisense oligonucleotides |
04/03/2014 | WO2012005898A3 Chinese hamster ovary (cho) cell transcriptome, corresponding sirnas and uses thereof |
04/03/2014 | US20140096289 Capsicum rootstock |
04/03/2014 | US20140096288 MICROSOMAL omega6 OLEATE DESATURASES |
04/03/2014 | US20140096286 Promoter, promoter control elements, and combinations, and uses thereof |
04/03/2014 | US20140096285 Soybean-based porcine reproductive and respiratory syndrome virus vaccine and methods for making and using the same |
04/03/2014 | US20140096284 Method for the delivery of molecules lyophilized onto microparticles to plant tissues |
04/03/2014 | US20140096283 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
04/03/2014 | US20140096282 Vaccine for control of beet curly top virus infection of plants |
04/03/2014 | US20140096280 Means and methods to induce apomixis in plants |
04/03/2014 | US20140096279 Barley cultivar bg-161 |
04/03/2014 | US20140096278 Methods and Compositions for Selecting an Improved Plant |
04/03/2014 | US20140096277 Melon hybrid sv1047mf and parents thereof |
04/03/2014 | US20140096276 Plants and seeds of common wheat culitvar xy06-892 |
04/03/2014 | US20140096275 Porcine reproductive and respiratory syndrome virus resistant animals |
04/03/2014 | US20140096273 Mouse for predicting a behavior of drugs in humans |
04/03/2014 | US20140094596 Process for manufacturing a composite sorbent material for chromatographical separation of biopolymers |
04/03/2014 | US20140094595 Protein Scaffolds for Antibody Mimics and Other Binding Proteins |
04/03/2014 | US20140094587 Filamentous fungi having an altered viscosity phenotype |
04/03/2014 | US20140094504 Human toll-like receptor inhibitors and methods of use thereof |
04/03/2014 | US20140094503 Rna interference mediated inhibition of isocitrate dehydrogenase (idh1) gene expression |
04/03/2014 | US20140094502 RNAi INHIBITION OF CTGF FOR TREATMENT OF OCULAR DISORDERS |
04/03/2014 | US20140094501 SiRNA Sequence-Independent Modification Formats for Reducing Off-Target Phenotypic Effects in RNAi, and Stabilized Forms Thereof |
04/03/2014 | US20140094500 Multiple exon skipping compositions for dmd |
04/03/2014 | US20140094399 Biodegradable poly(beta-amino esters) and uses thereof |
04/03/2014 | US20140094390 siRNA Targeting TIE-2 |
04/03/2014 | US20140094384 Stromal antigen 2 (stag2) compositions and methods |
04/03/2014 | US20140093964 Delivery of biological materials into cellular organelles |
04/03/2014 | US20140093956 Modified Human Thymic Stromal Lymphopoietin |
04/03/2014 | US20140093946 System for optimizing the introduction of nucleic acids into cells using magnetic particles |
04/03/2014 | US20140093944 Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of dna |
04/03/2014 | US20140093941 PROKARYOTIC RNAi-LIKE SYSTEM AND METHODS OF USE |
04/03/2014 | US20140093940 Polypeptides Having Cellulolytic Enhancing Activity And Nucleic Acids Encoding Same |
04/03/2014 | US20140093937 Protein removal agent |
04/03/2014 | US20140093936 Type ii restriction modification system methylation subunit of alicyclobacillus acidocaldarius |
04/03/2014 | US20140093913 Methods and compositions for treatment of a genetic condition |
04/03/2014 | US20140093910 D5 desaturase-defective mutant gene and use thereof |
04/03/2014 | US20140093888 Highly pure plasmid dna preparations |
04/03/2014 | US20140093885 Method of anaerobic tissue-targeted gene expression initiated by alcohol dehydrogenase promoter and the application thereof |
04/03/2014 | US20140093875 Mammalian cytokines; receptors; related reagents and methods |
04/03/2014 | US20140093542 Regulators of nfat and/or store-operated calcium entry |
04/03/2014 | US20140093540 Immunogenic compositions and expression systems |
04/03/2014 | US20140093533 Polypeptides and vectors for targeting her2/neu expressing cells and uses thereof |
04/03/2014 | US20140093501 Human-Murine Chimeric Antibodies Against Respiratory Syncytial Virus |
04/03/2014 | US20140093494 Alpha synuclein toxicity |
04/03/2014 | US20140093490 Glutamate release from astrocyte |
04/03/2014 | US20140093476 Methods for treating pain |
04/03/2014 | DE102008013304B4 Verfahren und Expressionsstamm zur heterologen Genexpression Methods and expression strain for heterologous gene expression |
04/02/2014 | EP2712931A1 Immobilized transposase complexes for DNA fragmentation and tagging |
04/02/2014 | EP2712927A1 Recombinant vaccine against prrs in a viral vector |
04/02/2014 | EP2712926A2 Compositions and methods for inhibiting expression of Eg5 and VEGF genes |
04/02/2014 | EP2712925A1 Protein removal agent |
04/02/2014 | EP2712924A1 Method of detecting heat-resistant fungus |
04/02/2014 | EP2712923A1 Method of detecting heat-resistant fungus |
04/02/2014 | EP2712922A1 Method of detecting heat-resistant fungus |
04/02/2014 | EP2712871A1 Recombinant Measles virus expressing Chikungunya virus polypeptides and their applications |
04/02/2014 | EP2634194A9 Anti-cdh3 antibody having high internalization capacity |
04/02/2014 | EP2476748A9 Culture method for hematopoietic stem cells |
04/02/2014 | CN203513676U Extraction device of bacteria DNA (Desoxvribose Nucleic Acid) in enrichment broth |